The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells
Open accessAbstract
CD44 is an integral hyaluronan receptor that can promote or inhibit motogenic signaling in tumor cells. Rhamm is a nonintegral cell surface hyaluronan receptor (CD168) and intracellular protein that promotes cell motility in culture. Here we describe an autocrine mechanism utilizing cell surface Rhamm-CD44 interactions to sustain rapid basal motility in invasive breast cancer cell lines that requires endogenous hyaluronan synthesis and the formation of Rhamm-CD44-ERK1,2 complexes. Motile/invasive MDA-MB-231 and Ras-MCF10A cells produce more endogenous hyaluronan, cell surface CD44 and Rhamm, an oncogenic Rhamm isoform, and exhibit more elevated basal activation of ERK1,2 than less invasive MCF7 and MCF10A breast cancer cells. Furthermore, CD44, Rhamm, and ERK1,2 uniquely co-immunoprecipitate and co-localize in MDA-MB-231 and Ras-MCF10A cells. Combinations of anti-CD44, anti-Rhamm antibodies, and a MEK1 inhibitor (PD098059) had less-than-additive blocking effects, suggesting the action of all three proteins on a common motogenic signaling pathway. Collectively, these results show that cell surface Rhamm and CD44 act together in a hyaluronan-dependent autocrine mechanism to coordinate sustained signaling through ERK1,2, leading to high basal motility of invasive breast cancer cells. Therefore, an effect of CD44 on tumor cell motility may depend in part on its ability to partner with additional proteins, such as cell surface Rhamm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Soule, H. D., Maloney, T., Wolman, S. R., Peterson, W., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., & Brooks, S. C. (1990) · PubMed · Cited by 1,507
Signaling Properties of Hyaluronan Receptors
Turley, E. A., Noble, P. W., & Bourguignon, L. Y. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100038200 · Cited by 1,041
Self-citationCD44: Structure, Function and Association with the Malignant Process
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60101-3 · Cited by 1,016
Sheridan, C., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C. H., Goulet, R., Badve, S., & Nakshatri, H. (2006) · Breast Cancer Research · doi:10.1186/bcr1610 · Cited by 993
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
Camenisch, T. D., Spicer, A. P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M. L., Calabro, A., Kubalak, S., Klewer, S. E., & McDonald, J. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10272 · Cited by 901
Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., Datar, R. H., & Cote, R. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0169 · Cited by 681
Naor, D., Nedvetzki, S., Golan, I., Melnik, L., & Faitelson, Y. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795574 · Cited by 557
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
Jalkanen, S., & Jalkanen, M. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.3.817 · Cited by 530
Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., & Brauch, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1154.11.3 · Cited by 527
Role of MAP kinase in tumor progression and invasion
Reddy, K. B., Nabha, S. M., & Atanaskova, N. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023781114568 · Cited by 509
Hyaluronan-Cell Interactions in Cancer and Vascular Disease
Toole, B. P., Wight, T. N., & Tammi, M. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100039200 · Cited by 491
Yu, W.-H., Woessner, J. F., McNeish, J. D., & Stamenkovic, I. (2002) · Genes & Development · doi:10.1101/gad.925702 · Cited by 471
Hyaluronan and Homeostasis: A Balancing Act
Tammi, M. I., Day, A. J., & Turley, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100037200 · Cited by 462
Self-citationCD44 in Cancer Progression: Adhesion, Migration and Growth Regulation
Marhaba, R., & Zöller, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032354.94213.69 · Cited by 438
Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling
Pouysségur, J., Volmat, V., & Lenormand, P. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01135-8 · Cited by 421
The role of mitogen-activated protein (MAP) kinase in breast cancer
Santen, R. J., Song, R. X., McPherson, R., Kumar, R., Adam, L., Jeng, M.-H., & Yue, W. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00189-3 · Cited by 406
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
Hardwick, C., Hoare, K., Owens, R., Hohn, H., Hook, M., Moore, D., Cripps, V, Austen, L., Nance, D., & Turley, E. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.6.1343 · Cited by 402
Self-citationHeparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective
Götte, M., & Yip, G. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1464 · Cited by 340
Savani, R. C., Cao, G., Pooler, P. M., Zaman, A., Zhou, Z., & DeLisser, H. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102273200 · Cited by 336
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters
Entschladen, F., Drell, T. L., Lang, K., Joseph, J., & Zaenker, K. S. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01431-7 · Cited by 334
Tumor Invasion: Role of Growth Factor-Induced Cell Motility
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61023-4 · Cited by 330
Tumor reversion: Correction of malignant behavior by microenvironmental cues
Kenny, P. A., & Bissell, M. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11491 · Cited by 326
Self-citationHall, C. L., Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90048-9 · Cited by 293
Self-citationThe BRCA1/BARD1 Heterodimer Modulates Ran-Dependent Mitotic Spindle Assembly
Joukov, V., Groen, A. C., Prokhorova, T., Gerson, R., White, E., Rodriguez, A., Walter, J. C., & Livingston, D. M. (2006) · Cell · doi:10.1016/j.cell.2006.08.053 · Cited by 280
Sef Is a Spatial Regulator for Ras/MAP Kinase Signaling
Torii, S., Kusakabe, M., Yamamoto, T., Maekawa, M., & Nishida, E. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.05.019 · Cited by 278
Bourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
Wang, F., Hansen, R. K., Radisky, D., Yoneda, T., Barcellos-Hoff, M. H., Petersen, O. W., Turley, E. A., & Bissell, M. J. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1494 · Cited by 270
Self-citationCI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
ALLEN, L. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.012 · Cited by 257
Hall, C. L., Wang, C., Lange, L. A., & Turley, E. A. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.575 · Cited by 231
Self-citationBourguignon, L. Y. W., Singleton, P. A., Zhu, H., & Zhou, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204320200 · Cited by 224
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
Udabage, L., Brownlee, G. R., Nilsson, S. K., & Brown, T. J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.026 · Cited by 223
The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase
Zhang, S., Chang, M. C. Y., Zylka, D., Turley, S., Harrison, R., & Turley, E. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11342 · Cited by 210
Self-citationHyaluronan and cell locomotion
Turley, E. A. (1992) · Cancer and Metastasis Review · doi:10.1007/bf00047600 · Cited by 201
Self-citationSavani, R. C., Wang, C., Yang, B., Zhang, S., Kinsella, M. G., Wight, T. N., Stern, R., Nance, D. M., & Turley, E. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117764 · Cited by 200
Self-citationRHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability
Maxwell, C. A., Keats, J. J., Crainie, M., Sun, X., Yen, T., Shibuya, E., Hendzel, M., Chan, G., & Pilarski, L. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0377 · Cited by 194
Nedvetzki, S., Gonen, E., Assayag, N., Reich, R., Williams, R. O., Thurmond, R. L., Huang, J.-F., Neudecker, B. A., Wang, F.-S., Turley, E. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407378102 · Cited by 193
Self-citationThe biology of breast carcinoma
Keen, J. C., & Davidson, N. E. (2003) · Cancer · doi:10.1002/cncr.11126 · Cited by 189
The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments
Assmann, V., Jenkinson, D., Marshall, J. F., & Hart, I. R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.22.3943 · Cited by 187
CD44 is the Principal Mediator of Hyaluronic-Acid-Induced Melanoma Cell Proliferation
Assmann, V., Fieber, C., Herrlich, P., Hofmann, M., Termeer, C. C., Ahrens, T., & Simon, J. C. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.00236.x · Cited by 186
Wang, C., Thor, A. D., Moore, D. H., Zhao, Y., KERSCHMANN, R. L., Stern, R., Watson, P. H., & Turley, E. A. (1998) · PubMed · Cited by 181
Self-citationCD44 Attenuates Metastatic Invasion during Breast Cancer Progression
Lopez, J. I., Camenisch, T. D., Stevens, M. V., Sands, B. J., McDonald, J., & Schroeder, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0863 · Cited by 178
Ge, L., Shenoy, S. K., Lefkowitz, R. J., & DeFea, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410312200 · Cited by 177
Navolanic, P., Steelman, L., & McCubrey, J. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.2.237 · Cited by 176
Tolg, C., Hamilton, S. R., Nakrieko, K.-A., Kooshesh, F., Walton, P., McCarthy, J. B., Bissell, M. J., & Turley, E. A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200511027 · Cited by 175
Self-citationHyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer
Adamia, S., Maxwell, C., & Pilarski, L. (2005) · Current Drug Target -Cardiovascular & Hematological Disorders · doi:10.2174/1568006053005056 · Cited by 169
Dual Role of Transforming Growth Factor β in Mammary Tumorigenesis and Metastatic Progression
Muraoka-Cook, R. S., Dumont, N., & Arteaga, C. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.937s.11.2 · Cited by 168
Bourguignon, L. Y. W., Gilad, E., Rothman, K., & Peyrollier, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411985200 · Cited by 161
Transformation of Human Breast Epithelial Cells by c‐Ha‐ras Oncogene
Basolo, F., Elliott, J., Tait, L., Chen, X. Q., Maloney, T., Russo, I. H., Pauley, R., Momiki, S., Caamano, J., Klein‐Szanto, A. J. P., et al. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040106 · Cited by 160
Krueger, J. S., Keshamouni, V. G., Atanaskova, N., & Reddy, K. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204541 · Cited by 159
CD44-Mediated Oncogenic Signaling and Cytoskeleton Activation During Mammary Tumor Progression
Bourguignon, L. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011371523994 · Cited by 152
Absence of the CD44 gene prevents sarcoma metastasis.
Weber, G. F., Bronson, R. T., Ilagan, J., Cantor, H., Schmits, R., & Mak, T. W. (2002) · PubMed · Cited by 141
Bakkers, J., Kramer, C., Pothof, J., Quaedvlieg, N. E. M., Spaink, H. P., & Hammerschmidt, M. (2004) · Development · doi:10.1242/dev.00954 · Cited by 140
Breast cancer stem cells: An overview
Ponti, D., Zaffaroni, N., Capelli, C., & Daidone, M. G. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.031 · Cited by 139
pp60(c-src) is required for cell locomotion regulated by the hyaluronanreceptor RHAMM.
Hall, C. L., Lange, L., Da, P., Zhang, S., & Ea, T. (1996) · PubMed · Cited by 139
Mohapatra, S. S., Yang, X., Wright, J. R., Turley, E. A., & Greenberg, A. H. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1663 · Cited by 132
Self-citationThe human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells
Assmann, V., Marshall, J. F., Fieber, C., Hofmann‐Apitius, M., & Hart, I. R. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.12.1685 · Cited by 131
Udabage, L., Brownlee, G. R., Waltham, M. C., Blick, T., Walker, E. C., Heldin, P., Nilsson, S. K., Thompson, E. W., & Brown, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1622 · Cited by 131
Regulatory Mechanisms and Function of ERK MAP Kinases
Torii, S. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh159 · Cited by 125
Expression and Role of the Hyaluronan Receptor RHAMM in Inflammation after Bleomycin Injury
Zaman, A., Cui, Z., Foley, J. P., Zhao, H., Grimm, P. C., DeLisser, H. M., & Savani, R. C. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0333oc · Cited by 124
Goebeler, M., Kaufmann, D., Bröcker, E., & Klein, C. E. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.7.1957 · Cited by 118
Tzircotis, G., Thorne, R. F., & Isacke, C. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02629 · Cited by 117
Khan, S. A., Cook, A. C., Kappil, M., Günthert, U., Chambers, A., Tuck, A., & Denhardt, D. (2006) · Clinical and Experimental Metastasis · doi:10.1007/s10585-006-9007-0 · Cited by 111
Gouëffic, Y., Guilluy, C., Guérin, P., Patra, P., Pacaud, P., & Loirand, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.07.017 · Cited by 106
Estrogen receptor mediated inhibition of cancer cell invasion and motility: An overview
Rochefort, H., Platet, N., Hayashido, Y., Derocq, D., Lucas, A., Cunat, S., & Garcia, M. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00010-7 · Cited by 103
Sohara, Y., Ishiguro, N., Machida, K., Kurata, H., Thant, A. A., Senga, T., Matsuda, S., Kimata, K., Iwata, H., & Hamaguchi, M. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.6.1859 · Cited by 97
Regulation of Tumor Cell Motility by ERK Mitogen‐Activated Protein Kinases
Vial, E., & Pouysségur, J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.027 · Cited by 97
Pilarski, L. M., Pruski, E., Wizniak, J., Paine, D., Seeberger, K. L., Mant, M. J., Brown, C. B., & Belch, A. R. (1999) · Blood · doi:10.1182/blood.v93.9.2918 · Cited by 93
Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein
Hofmann‐Apitius, M., Fieber, C., Assmann, V., Göttlicher, M., Sleeman, J. P., Plug, R., Howells, N., von Stein, O. D., Ponta, H., & Herrlich, P. A. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.12.1673 · Cited by 90
Control of MAP kinase signaling to the nucleus
Kondoh, K., Torii, S., & Nishida, E. (2005) · Chromosoma · doi:10.1007/s00412-005-0341-9 · Cited by 89
Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman, J. P., Arming, S., Moll, J. F., Hekele, A., Rudy, W., Sherman, L. S., Kreil, G., Ponta, H., & Herrlich, P. (1996) · PubMed · Cited by 87
Functions of MAP Kinases: Insights from Gene-Targeting Studies
Kuida, K., & Boucher, D. M. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh078 · Cited by 84
CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma
Diaz, L. K., Zhou, X., Wright, E. T., Cristofanilli, M., Smith, T., Yang, Y., Sneige, N., Şahin, A. A., & Gilcrease, M. Z. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2184 · Cited by 84
Savani, R. C., Hou, G., Liu, P., Wang, C., Simons, E., Grimm, P. C., Stern, R., Greenberg, A. H., DeLisser, H. M., & Khalil, N. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.4.3944 · Cited by 81
Self-citationTargeting key steps in metastatic tumour progression
Eccles, S. A. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.001 · Cited by 73
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells
Galluzzo, E., Albi, N., Fiorucci, S., Merigiola, C., Ruggeri, L., Tosti, A., Grossi, C. E., & Velardi, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251033 · Cited by 72
Auvinen, P., Tammi, R., Tammi, M., Johansson, R. T., & Kosma, V. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02220.x · Cited by 63
Edward, M., Gillan, C., Micha, D., & Tammi, R. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi064 · Cited by 59
Lynn, B. D., Li, X., Cattini, P. A., Turley, E. A., & Nagy, J. I. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1353 · Cited by 52
Self-citationTargeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Boldt, S., & Kölch, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384420 · Cited by 48
Ochieng, J., Basolo, F., Albini, A., Melchiori, A., Watanabe, H., Elliott, J., Raz, A., Parodi, S., & Russo, J. (1991) · PubMed · Cited by 44
Fibroblasts require protein kinase C activation to respond to hyaluronan with increased locomotion
Hall, C. L., Collis, L., Jing Bo, A., Lange, L., McNicol, A., Gerrard, J. M., & Turley, E. A. (2001) · Matrix Biology · doi:10.1016/s0945-053x(01)00133-0 · Cited by 41
Self-citationWatanabe, O., Kinoshita, J., Shimizu, T., Imamura, H., Hirano, A., Okabe, T., Aiba, M., & Ogawa, K. (2005) · PubMed · Cited by 40
Flow cytometric analysis of the Hermes homing-associated antigen on human lymphocyte subsets
Toyos, J. R. D. L., Jalkanen, S., & Butcher, E. C. (1989) · Blood · doi:10.1182/blood.v74.2.751.751 · Cited by 28
Rom, J., Aulmann, S., Schneeweiß, A., Sohn, C., & Sinn, H. (2006) · Pathology - Research and Practice · doi:10.1016/j.prp.2005.12.002 · Cited by 3
Cited by
A guide to the composition and functions of the extracellular matrix
Karamanos, N. K., Theocharis, A. D., Piperigkou, Z., Manou, D., Passi, A., Skandalis, S. S., Vynios, D. H., Orian‐Rousseau, V., Ricard‐Blum, S., Schmelzer, C. E. H., et al. (2021) · The FEBS Journal · doi:10.1111/febs.15776 · Cited by 1,090
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
Hyaluronan: A simple polysaccharide with diverse biological functions
Dicker, K. T., Gurski, L. A., Pradhan-Bhatt, S., Witt, R. L., Farach-Carson, M. C., & Jia, X. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.12.019 · Cited by 671
Epithelial-Mesenchymal Transition
Klymkowsky, M. W., & Savagner, P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080545 · Cited by 557
Metadata
- Authors
- Hamilton, S. R., Fard, S. F., Paiwand, F. F., Tolg, C., Veiseh, M., Wang, C., McCarthy, J. B., Bissell, M. J., Koropatnick, J., & Turley, E. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 282
- Issue
- 22
- Pages
- 16667-16680
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2024823422
- Cited by
- 266
- References
- 88
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.